Title : Effect of rimonabant on glycemic control in insulin-treated type 2 diabetes: the ARPEGGIO trial.

Pub. Date : 2010 Mar

PMID : 20009090






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE To examine the efficacy and safety of rimonabant, a selective cannabinoid receptor type-1 antagonist, in patients with type 2 diabetes receiving insulin monotherapy. Rimonabant insulin Homo sapiens